Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.3
5.5
Journals
Biomolecules
Special Issues
Eosinophilic Inflammation
share announcement

Eosinophilic Inflammation

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 15043

Special Issue Editors

Prof. Dr. Akira Kanda

E-Mail
Guest Editor
Center of Laboratory Medicine, Kansai Medical University Hospital, Hirakata, Osaka, Japan
Interests: allergy; allergic rhinitis; asthma; eosinophils
Special Issues, Collections and Topics in MDPI journals
Dr. David Dombrowicz

E-Mail Website
Guest Editor
EGID, Inserm, CHU Lille, Institut Pasteur de Lille, U1011, University of Lille, 59019 Lille, France
Interests: allergy; inflammation; cardiac & cardiovascular systems

Special Issue Information

Dear colleagues,

The focus of this Special Issue is eosinophilic inflammation such as allergic rhinitis, asthma, chronic rhinosinusitis with nasal polyp, esophagitis, gastroenteritis, and otitis media.

Eosinophils are key contributors to Th2-associated pathologies such as allergic disorders. They also function as effectors in the innate immune response through the expression of Toll-like receptors. In the inflamed site, activated eosinophils exert their effects through cytotoxic mediators, comprising granules (EPO, MBP, ECP, and EDN), cytokines, chemokines, and lipid mediators, resulting in tissue damage. However, little is known about the mechanisms of pathogenesis by activated eosinophils.  

Here, we focus not only all clinical investigations involved in eosinophils-derived disorders but also basic on investigations in vitro and in vivo using animal models.   

Prof. Dr. Akira Kanda
Dr. David Dombrowicz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • airway inflammation
  • allergic rhinitis
  • asthma
  • chronic rhinosinusitis with nasal polyp
  • eosinophil
  • esophagitis
  • gastroenteritis
  • otitis media
  • united airway disease
  • atopic dermatitis
  • airway hyperresponsiveness (AHR)

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 16272 KiB  
Article
Enhanced 15-Lipoxygenase 1 Production is Related to Periostin Expression and Eosinophil Recruitment in Eosinophilic Chronic Rhinosinusitis
by Yoshimasa Imoto, Tetsuji Takabayashi, Masafumi Sakashita, Yukinori Kato, Kanako Yoshida, Masanori Kidoguchi, Keisuke Koyama, Naoto Adachi, Yukihiro Kimura, Kazuhiro Ogi, Yumi Ito, Masafumi Kanno, Masayuki Okamoto, Norihiko Narita and Shigeharu Fujieda
Biomolecules 2020, 10(11), 1568; https://0-doi-org.brum.beds.ac.uk/10.3390/biom10111568 - 18 Nov 2020
Cited by 16 | Viewed by 2971
Abstract
Background: The pathological features of chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) tissues include an eosinophilic infiltration pattern (eosinophilic CRS (ECRS)) or a less eosinophilic pattern (non-ECRS). Recently, it has been suggested that 15-lipoxygenase 1 (15-LOX-1) may have significant roles in allergic disease; [...] Read more.
Background: The pathological features of chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) tissues include an eosinophilic infiltration pattern (eosinophilic CRS (ECRS)) or a less eosinophilic pattern (non-ECRS). Recently, it has been suggested that 15-lipoxygenase 1 (15-LOX-1) may have significant roles in allergic disease; however, the significance of 15-LOX-1 in CRS is not well understood. The objective of this study was to demonstrate the expression of 15-LOX-1 in CRS. Methods: The mRNA expression levels of 15-LOX-1 and periostin in nasal tissues were measured by quantitative real-time polymerase chain reaction. We also performed an immunofluorescence study of nasal tissues. Cells of the Eol-1 eosinophilic leukemic cell line were stimulated with interleukin-33 to test the induction of 15-LOX-1. Results: The expression level of 15-LOX-1 mRNA in nasal polyps (NPs) was significantly higher in ECRS patients than in non-ECRS patients. The immunofluorescence study revealed that both airway epithelial cells and eosinophils in NPs expressed 15-LOX-1. A significant correlation was seen between the number of eosinophils and the mRNA expression levels of 15-LOX-1 and periostin in nasal polyps. Moreover, interleukin-33 enhanced 15-LOX-1 expression in Eol-1 cells. Conclusions: 15-LOX-1 was shown to be a significant molecule that facilitates eosinophilic inflammation in ECRS. Full article
(This article belongs to the Special Issue Eosinophilic Inflammation)
►▼ Show Figures

Graphical abstract

9 pages, 1804 KiB  
Article
Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma
by Yoshiki Kobayashi, Akira Kanda, Yasutaka Yun, Dan Van Bui, Kensuke Suzuki, Shunsuke Sawada, Mikiya Asako and Hiroshi Iwai
Biomolecules 2020, 10(2), 326; https://doi.org/10.3390/biom10020326 - 18 Feb 2020
Cited by 11 | Viewed by 3712
Abstract
Eosinophilic chronic rhinosinusitis (ECRS), a subgroup of chronic rhinosinusitis with nasal polyps, is recognized as a refractory eosinophilic disorder characterized by both upper and lower airway inflammation. In some severe cases, disease control is poor, likely due to local steroid insensitivity. In this [...] Read more.
Eosinophilic chronic rhinosinusitis (ECRS), a subgroup of chronic rhinosinusitis with nasal polyps, is recognized as a refractory eosinophilic disorder characterized by both upper and lower airway inflammation. In some severe cases, disease control is poor, likely due to local steroid insensitivity. In this study, we focused on protein phosphatase 2A (PP2A), a key factor regulating glucocorticoid receptor (GR) nuclear translocation, and examined its association with local responses to corticosteroids in eosinophilic airway inflammation. Our results indicated reduced responses to corticosteroids in nasal epithelial cells from ECRS patients with asthma, which were also associated with decreased PP2A mRNA expression. Eosinophil peroxidase stimulates elevated PP2A phosphorylation levels, reducing PP2A protein expression and activity. In addition, mRNA levels of inflammatory mediators (TSLP, IL-25, IL-33, CCL4, CCL5, CCL11, and CCL26) associated with eosinophilic airway inflammation in epithelial cells were increased in nasal polyps (eosinophil-rich areas) compared with those in uncinate process tissues (eosinophil-poor areas) from the same patients. PP2A reduction by siRNA reduced GR nuclear translocation, whereas PP2A overexpression by plasmid transfection, or PP2A activation by formoterol, enhanced GR nuclear translocation. Collectively, our findings indicate that PP2A may represent a promising therapeutic target in refractory eosinophilic airway inflammation characterized by local steroid insensitivity. Full article
(This article belongs to the Special Issue Eosinophilic Inflammation)
►▼ Show Figures

Figure 1

11 pages, 2888 KiB  
Article
A Novel Approach for Investigating Upper Airway Hyperresponsiveness Using Micro-CT in Eosinophilic Upper Airway Inflammation such as Allergic Rhinitis Model
by Dan Van Bui, Akira Kanda, Yoshiki Kobayashi, Yoshiko Sakata, Yumiko Kono, Yoshiyuki Kamakura, Takao Jinno, Yasutaka Yun, Kensuke Suzuki, Shunsuke Sawada, Mikiya Asako, Akihiko Nakamura, David Dombrowicz, Keita Utsunomiya, Tanigawa Noboru, Koichi Tomoda and Hiroshi Iwai
Biomolecules 2019, 9(7), 252; https://0-doi-org.brum.beds.ac.uk/10.3390/biom9070252 - 27 Jun 2019
Cited by 1 | Viewed by 3138
Abstract
Airway hyperresponsiveness (AHR) has been proposed as a feature of pathogenesis of eosinophilic upper airway inflammation such as allergic rhinitis (AR). The measurement system for upper AHR (UAHR) in rodents is poorly developed, although measurements of nasal resistance have been reported. [...] Read more.
Airway hyperresponsiveness (AHR) has been proposed as a feature of pathogenesis of eosinophilic upper airway inflammation such as allergic rhinitis (AR). The measurement system for upper AHR (UAHR) in rodents is poorly developed, although measurements of nasal resistance have been reported. Here we assessed UAHR by direct measurement of swelling of the nasal mucosa induced by intranasal methacholine (MCh) using micro-computed tomography (micro-CT). Micro-CT analysis was performed in both naïve and ovalbumin-induced AR mice following intranasal administration of MCh. The nasal cavity was segmented into two-dimensional horizontal and axial planes, and the data for nasal mucosa were acquired for the region of interest threshold. Then, a ratio between the nasal mucosa area and nasal cavity area was calculated as nasal mucosa index. Using our novel method, nasal cavity structure was clearly identified on micro-CT, and dose-dependent increased swelling of the nasal mucosa was observed upon MCh treatment. Moreover, the nasal mucosa index was significantly increased in AR mice compared to controls following MCh treatment, while ovalbumin administration did not affect swelling of the nasal mucosa in either group. This UAHR following MCh treatment was completely reversed by pretreatment with glucocorticoids. This novel approach using micro-CT for investigating UAHR reflects a precise assessment system for swelling of the nasal mucosa following MCh treatment; it not only sheds light on the mechanism of AR but also contributes to the development of new therapeutic drugs in AR patients. Full article
(This article belongs to the Special Issue Eosinophilic Inflammation)
►▼ Show Figures

Figure 1

Review

Jump to: Research

12 pages, 1583 KiB  
Review
Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia
by Kazuyuki Nakagome and Makoto Nagata
Biomolecules 2020, 10(4), 638; https://0-doi-org.brum.beds.ac.uk/10.3390/biom10040638 - 21 Apr 2020
Cited by 19 | Viewed by 4617
Abstract
Eosinophilic pneumonia (EP), including acute EP and chronic EP, is characterized by the massive pulmonary infiltration of eosinophils into the lung. However, the mechanisms underlying the selective accumulation of eosinophils in EP have not yet been fully elucidated. We reported that bronchoalveolar lavage [...] Read more.
Eosinophilic pneumonia (EP), including acute EP and chronic EP, is characterized by the massive pulmonary infiltration of eosinophils into the lung. However, the mechanisms underlying the selective accumulation of eosinophils in EP have not yet been fully elucidated. We reported that bronchoalveolar lavage fluid (BALF) from EP patients induced the transmigration of eosinophils across endothelial cells in vitro. The concentrations of eotaxin-2 (CCL24) and monocyte chemotactic protein (MCP)-4 (CCL13), which are CC chemokine receptor (CCR) 3 ligands, were elevated in the BALF of EP patients, and anti-CCR3 monoclonal antibody inhibited the eosinophil transmigration induced by the BALF of EP patients. The concentration of macrophage inflammatory protein 1β (CCL4), a CCR5 ligand that induces eosinophil migration, was increased in the BALF of EP patients. Furthermore, the concentration of interleukin (IL) 5 was increased in the BALF of EP patients, and it has been reported that anti-IL-5 antibody treatment resulted in remission and the reduction of glucocorticoid use in some cases of chronic EP. The concentrations of lipid mediators, such as leukotriene (LT) B4, damage-associated molecular pattern molecules (DAMPs), such as uric acid, or extracellular matrix proteins, such as periostin, were also increased in the BALF of EP patients. These findings suggest that chemokines, such as CCR3/CCR5 ligands, cytokines, such as IL-5, lipid mediators, such as LTB4, DAMPs, and extracellular matrix proteins may play roles in the accumulation or activation of eosinophils in EP. Full article
(This article belongs to the Special Issue Eosinophilic Inflammation)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop